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Abstract.  The basement membrane heparan sulfate 
proteoglycan produced by the Englebreth-Holm-Swarm 
(EHS) tumor and by glomeruli were compared by im- 
munological methods. Antibodies to the EHS pro- 
teoglycan immunoprecipitated a  single precursor pro- 
tein (Mr  =  400,000)  from [35S]methionine-pulsed 
glomeruli, the same size produced by EHS cells. 
These antibodies detected both heparan sulfate pro- 
teoglycans and glycoproteins in extracts of unlabeled 
glomeruli and glomerular basement membrane.  The 
proteoglycans contained core proteins of varying size 
(Mr  =  150,000  to 400,000)  with a Mr  =  250,000  spe- 
cies being predominant. The glycoproteins are frag- 
ments of the core protein which lack heparan sulfate 
side chains. Antibodies to glomerular basement mem- 
brane proteoglycan immunoprecipitated the precursor 
protein (Mr  =  400,000)  synthesized by EHS cells and 
also reacted with most of the proteolytic fragments of 
the EHS proteoglycan. This antibody did not, how- 
ever, react with the P44 fragment, a peptide situated at 
one end of the EHS proteoglycan core protein.  These 
data suggest that the glomerular basement membrane 
proteoglycan is synthesized from a  large precursor 
protein which undergoes specific proteolytic pro- 
cessing. 
C 
ERTAIN tumor cells such as the Englebreth-Holm- 
Swarm (EHS) ~  tumor, parietal yolk sac carcinomas, 
embryonal carcinoma-derived endodermal cells, and 
NMuMG epithelial cells, have been useful model systems for 
characterizing components of basement membranes. These 
components include laminin (Timpl et al.,  1979; Chung et 
al.,  1979; Martinez-Hernandez et al.,  1982; Wewer,  1984), 
collagen IV (Orkin et al., 1977; Timpl et al., 1978; Kleinman 
et al., 1982), entactin/nidogen (Carlin et al., 1981; Timpl et 
al.,  1983), heparan  sulfate proteoglycan  (Hassell  et  al., 
1980; Oohira et al.,  1982; Tyree et al.,  1984; Ledbetter et 
al., 1985), and a proteoglycan containing both heparan sul- 
fate and chondroitin sulfate side  chains  (Jalkanen et al., 
1985; Kato et al., 1987). In addition, cDNA clones to colla- 
gen IV (Schwartz et al., 1986), laminin (Sasaki et al., 1987) 
and entactin (Durkin et al., 1987) have been obtained using 
RNA prepared from tumors. These and other studies have 
shown that native basement membranes contain components 
similar, at least at the immunological level, to those in tu- 
mors (Laurie et al.,  1982; Martinez-Hernandez and Arm- 
menta, 1983; Timpl and Dziadek, 1986; Martin and Timpl, 
1987). 
Heparan sulfate proteoglycans isolated to date from native 
1. Abbreviation  used in this paper:  EHS, Englebreth-Holm-Swarm. 
basement membranes are, however,  considerably different 
from those isolated from basement membrane producing 
tumors (for reviews see Hassell et al., 1986; GaUagher et al., 
1986;  Poole,  1986). The  major  EHS  proteoglycan  (Mr 
•600,000)  has a  large (Mr  =  400,000)  core protein with 
three heparan sulfate side chains of Mr -- 65,000 (Hassell et 
al., 1985b; Kato et al., 1985; Paulsson et al., 1987). Proteo- 
lytic fragmentation indicates that the core protein consists 
of two major domains; a trypsin sensitive domain (Mr  = 
200,000)  containing the heparan sulfate side chains and a 
trypsin resistant domain (Mr  =  200,000)  from which two 
small  peptides  can  be  generated by V-8  protease  (Mr  = 
44,000 and 46,000)  that are immunologically distinct from 
one another (Ledbetter et al.,  1987). The glomerular pro- 
teoglycan, (Kanwar et al.,  1981; Stow et al.,  1983; Partha- 
sarathy and Spiro,  1984; Klein et al.,  1986) in contrast, is 
smaller (Mr  =  130,000-200,000)  with four heparan sulfate 
side chains of Mr  =  12,000-30,000  attached to a core pro- 
tein ranging from Mr =  18,000 (Kanwar et al.,  1984) to Mr 
=  143,000 (Edge and Spiro, 1987). It is possible that the vari- 
ability in core protein size may be due to proteolysis. This 
has been noted in the EHS tumor, where a portion of the 
population of the proteoglycan was found to be proteolyti- 
cally processed to produce smaller proteoglycans with Mr 
￿9  The Rockefeller University Press, 0021-9525/88/03/963/8 $2.00 
The Journal of Cell Biology, Volume 106,  March 1988 963-970  963 =  95,000-130,000 core proteins (Ledbetter et al., 1985; Has- 
sell et al..  1985b). 
Despite the size differences between the EHS and glomer- 
ular proteoglycans,  antibodies to the EHS proteoglycan react 
strongly  with glomerular basement membranes as well as 
with all other basement membranes examined (Hassell et al., 
1980; Laurie et al.,  1982; Mynderse et al.,  1983). In this 
study we have used antibodies to the EHS proteoglycan  to 
characterize  the immunoreactive  material present in the glo- 
merular basement membrane and have studied the reaction 
of glomerular proteoglycan  antibodies with  the EHS pro- 
teoglycan. The results of this study indicate that the EHS and 
glomerular proteoglycan are similar but that the glomerular 
proteoglycan is proteolytically  processed to produce smaller 
proteoglycans. 
Materials and Methods 
Tissue and Cell Preparation 
Glomeruli were isolated from kidney cortices removed from  175 g  male 
Sprague-Dawley rats by serial sieving through wire meshes. The glomernli 
were retained on 150 and 200 mesh screens and collected by low speed cen- 
trifugation (Brown et al., 1981). These preparations contained less than 5 % 
tubular elements and the cells excluded trypan blue both before and after 
in vitro radiolabeling. Glomerular basement membrane was prepared from 
giomeruli by sequential treatment with distilled water, DNAse, and deoxy- 
cholate as previously described (Brown et al.,  1981). 
The EHS tumor was maintained by serial passage in the hind limbs of 
C57BL mice and harvested as previously described (Orkin et al.,  1977). 
Cells were isolated from freshly harvested EHS tumor by using a combina- 
tion of mechanical disruption and dispase digestion (Ledbetter et al., 1985). 
The isolated cells were plated at 4  x  106 cells/35-mm dish and were cul- 
tured overnight in NCTC  109 containing 10%  fetal bovine serum. 
EHS  cells  in culture were  radiolabeled for 20  min with 500  txCi  of 
135Slmethionine/ml in medium free of serum and methionine (Ledbetter et 
al.,  1985).  The cells were scraped from the dish at the end of the labeling 
period,  pelleted  by  centrifugation,  and  were  stored at  -70~  Isolated 
glomeruti were radiolabeted in organ culture using the same procedure, but 
with low speed centrifugation (400 g for 3 min) to pellet the glomeruli and 
to permit media changes. Approximately 100 ktl of pelleted glomeruli were 
suspended and radiolabeled in 1 ml of media containing the isotope.  The 
radiolabeled  glomeruli  were  collected  by  centrifugation  and  stored  at 
-70~ 
Unlabeled glomeruli and glomerular basement membranes were either 
briefly sonicated in 2% SDS containing 0.01 M phosphate buffer, pH 7.4, 
and heated at 100~  for 3 rain or extracted in 4 M guanidine-HCl containing 
0.05 M sodium acetate, 0.01 M EDTA, 0.005 M benzamidine-HCI, and 0.1 
M 6 aminohexanoic acid, pH 6.5, overnight at 4~  on a rocker. The protein 
content in the SDS extract was measured with Folin reagent (Lowry et al., 
1951). The guanidine extract was dialyzed against 6 M urea containing 0.15 
M  NaCl,  0.t%  CHAPS and 0.05  M  Tris-HC1,  pH 6.8,  and applied to a 
column (t.5  X  1.5 cm) of DEAE Sephacel equilibrated with the same sol- 
vent. The eluent was monitored at 280 nM. After the unbound glycoprotein 
fraction was washed from the column the bound proteoglyean fraction was 
eluted with the same solvent containing 1.0 M Natl.  The glycoprotein and 
proteoglycan fractions were dialyzed against distilled water,  lyophilized, 
and reconstituted in distilled water. An aliquot of the proteoglycan fraction 
was digested with heparitinase (Hassell, et al.,  1985b; Kato et al.,  1985). 
The completeness of hepartinase digestion was checked by the addition of 
more hepartinase. The samples were adjusted to 2% SDS and 0.01 M  so- 
dium phosphate buffer, pH 7.4, and boiled for 3 min before PAGE. Molecu- 
lar weight markers, obtained from Bio-Rad Laboratories (Richmond, CA), 
and laminin were used as standards. 
Antigen Purification and Immunologic Procedures 
The EHS proteoglycan was purified from urea extracts of the EHS tumor 
(Ledbetter et al., 1987). After washing the tissue with 3.4 M NaCI, the resi- 
due is extracted with 6 M urea and the large, low density proteoglycan was 
isolated by sequential use of DEAE Sephacel column chromatography, CsCI 
density gradient centrifugation, and Sephamse CL-4B column chromatog- 
raphy.  Proteolytic digestion of this purified proteoglycan was conducted in 
0.02 M Tris-HC1, pH 8.0, containing 1 mg/ml of proteogtycan and 10 lxg/ml 
of either V8 protease (Miles Laboratories, Inc., Naperville, IL) or Trypsin 
(Sigma Chemical Co.,  St.  Louis,  MO) at 37~  (Ledbetter et al.,  1987). 
Purification of the 1o200 P46 and P44 core protein fragments was accom- 
plished by  sequential  chromatography  on  sepharose CL-6B  and  DEAE 
5PW (Ledbetter et al.,  1987).  Glomeruli and glomerular basement mem- 
brane were isolated from fresh bovine kidneys as previously described (Par- 
thasarathy and  Spiro,  1984).  The glomernlar proteoglycan  was  purified 
from preparations of bovine glomerular basement membrane by extraction 
with 4 M guanidine-HC1 followed by dialysis against 7 M urea and chroma- 
tography on a DEAE Sephacel column (Brenchley, P. E, M. A. J. Dickin- 
son, and J. C. Anderson, manuscript in preparation). Antibodies to the EHS 
proteoglycans, the glomerular proteoglycan and laminin were raised in rab- 
bits using the same method (Hassell et al.,  1980;  Hassell et al.,  1985b; 
Brenchley, P.  E.,  M. A. J. Dickinson, and J. C.  Anderson, manuscript in 
preparation; Foidart et al.,  1980). 
Antibodies to the EHS proteoglycan were purified by affinity chromatog- 
raphy. EHS proteogtycan core protein was produced by heparitinase diges- 
tion of 10 mg of proteoglycan and isolated by chromatography on Sepharose 
CL-4B in 4  M guanidine-HCl.  The purified core protein was coupled to 
20 ml of CNBr-activated Sepharose CL-4B according to the manufacturer's 
(Pharmacia Fine Chemicals, Piscataway,  N J) instructions. Antibodies were 
purified from antisera by circulating 10 ml of antiserum overnight at 4~ 
removing  unbound material  with  PBS and bound IgG with 4M  guani- 
dine-HCl, 0.05 M Tris-HC1, pH 7.0. The etuted lgG was dialyzed against 
0.15 M NaCI, 0.01 M  sodium phosphate, pH 7.4, and then adjusted to the 
same volume of serum originally applied to the coupled resin. 
Immunoprecipitation of protein from extracts of radiolabeled ceils and 
glomeruli  was  accomplished  as  described  previously  (Ledbetter  et  al., 
1985).  In brief, cells were lysed in a buffered detergent solution and a por- 
tion of the lysate was mixed with Protein A-Sepharose beads pre-bound with 
the  antibodies or  antisera.  The  beads  were  then  washed and  the anti- 
gen-antibody complex on the beads was solubilized in 0.01 M sodium phos- 
phate buffer, pH 7.4, containing 2 % SDS and 0.1 M dithiothreitol by heating 
100~  for 3 min. The solubilized proteins were separated by PAGE in 0.1% 
SDS (Laemmli,  1970) and gels were prepared for fluorography with Auto- 
fluor (National  Diagnostics,  Somerville,  NJ)  according to the manufac- 
turers instructions. 
Electrophoretic  transfer of proteins  to  nitrocellulose  from polyacryl- 
amide gels was accomplished in a buffer containing 20%  methanol at 90 
V overnight at 4~  (Towbin et aL,  1979). Subsequent steps were done at 
room temperature. Unused binding sites on the nitrocellulose were blocked 
with 3 % gelatin in TBS (0.02 M Tris HCI, pH 7.5, containing 0.5 M NaCI), 
exposed to the anti-proteoglycan antibody or antisera diluted 1:200 in 1% 
gelatin in TBS for 2 h, rinsed in TBS, exposed to horseradish-peroxidase- 
conjugated goat anti-rabbit IgG diluted 1:2,000 in 1% gelatin in TBS for 
2 h, rinsed again in TBS, and the color developed with 0.05 % 4-chloro-1- 
naphthol in TBS containing 15%  methanol and 0.001%  H202.  Unblocked 
nitrocellulose filters were stained for protein with amido black. Enzyme- 
linked immunoabsorbent assays (ELISA) were conducted, as previously de- 
scribed (Rennard et al.,  1981), using polystyrene plates, Voller's buffer for 
coating fragments on the plates, PBS-tween as the rinsing buffer, and the 
second antibody described above. 
Results 
The immunostaining of kidney  sections with antibodies to 
the EHS  proteoglycan indicated that the glomerular base- 
ment membrane contains immunologically related  material 
(Hassell et al.,  1980; Laurie et al.,  1982;  Mynderse et al., 
1983).  Consequently,  to identify this material,  extracts  of 
both glomeruli and glomerular basement membrane were 
subjected to electrophoresis and examined for reaction with 
the antibodies to the EHS proteoglycan by Western blot anal- 
ysis.  Extracts  of glomeruli  contained  three  diffuse broad 
bands  (Mr =  400,000, 200,000, and 150,000)  which reacted 
with the antibody  to the EHS proteoglycan (Fig.  1, lane A). 
Extracts  of glomerular basement membrane contained the 
Mr =  200,000 and 150,000 bands as well as several  smaller 
components that reacted with the antibody (Fig.  1, lane B). 
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preimmune serum with SDS extracts of glomeruli and glomerular 
basement  membrane  subjected to electrophoresis  on polyacryl- 
amide gels and transferred to nitrocellulose. Extracts from glomer- 
uli containing 80 ~tg protein (lanes A and C) and extracts from glo- 
merular basement membrane containing 4 txg protein (lanes B and 
D) were subjected to electrophoresis without reduction on poly- 
acrylamide gels containing 5 % running gels. The material trans- 
ferred to nitrocellulose was reacted with antibodies to EHS pro- 
teoglycan (lanes A and B) or preimmune serum (lanes C and D). 
No reaction was observed with preimmune serum (Fig.  1, 
lanes C and D). It should be noted that the amount of protein 
subjected to electrophoresis from the two extracts was  ad- 
justed (80 Ixg for glomeruli; 4  Ixg for glomerular basement 
membrane) to produce approximately equivalent immuno- 
staining on the nitrocellulose (Fig.  1, lanes A and B). The 
20-fold higher immunoreactivity of  the glomerular basement 
membrane protein over the glomeruli protein reflects an en- 
richment due to purification of basement membrane and in- 
dicates the antigenic determinants detected in the extracts of 
glomeruli were primarily from the basement membrane and 
not from the cells. 
The glycoproteins and proteoglycans in guanidine extracts 
of glomeruli  and  glomerular  basement  membranes  were 
separated by DEAE-Sephacel column chromatography, sub- 
jected to electrophoresis, and then analyzed for reactivity 
with the antibody to the EHS proteoglycan in Western blots. 
The pattern of immunoreactive bands  in  the  glycoprotein 
fractions from both the glomeruli (Fig. 2,  lane A) and the 
glomerular basement membrane (Fig. 2, lane D) was similar 
to  that  previously observed  in  unfractionated  extracts  of 
these tissues (Fig.  1, lanes A and B, respectively). The Mr 
=  400,000 band in the unfractionated extract of glomeruli 
(Fig.  1, lane A), however, appeared reduced or absent in the 
glycoprotein fraction from glomeruli (Fig. 2, lane A) and the 
undigested proteoglycan fraction from glomeruli contained 
Figure 2. Immunoreaction of antibodies to EHS proteoglycan with 
glycoprotein and proteoglycan fractions from extracts of glomeruli 
and glomerular basement membranes subjected to electrophoresis 
on polyacrylamide gels and transferred to nitrocellulose. Glycopro- 
tein and proteoglycan fractions were isolated from guanidine-HCl 
extracts by column chromatography on DEAE-Sepharose and ap- 
plied unreduced to 5 % polyacrylamide gels (Lane A) Glycoprotein 
fraction from glomeruli; (lane B) proteoglycan fraction from glo- 
meruli digested with heparitinase; (lane C) proteoglycan fraction 
from glomeruli;  (lane D) glycoprotein fraction from glomerular 
basement membranes; (lane E) proteoglycan fraction from glomer- 
ular basement membranes digested with heparitinase; (lane F) pro- 
teoglycan fraction from glomerular basement membranes; (lane G) 
heparitinase. Equivalent amounts of immunoreactive material was 
loaded in lanes A, B, and C, and in lanes D, E, and E 
a broad immunoreactive band at Mr =  400,000 (Fig. 2, lane 
C).  Heparitinase digestion of either glycoprotein fraction 
did not alter the migration position of the immunoreactive 
material (not shown). In contrast, Heparitinase digestion of 
the proteoglycan fraction from glomeruli produced a major 
immunoreactive band at M~ =  250,000 (Fig. 2, lane B) and 
somewhat lesser amounts of two broad but larger bands (Mr 
=  300,000 and 400,000). These bands are core proteins from 
the glomerular proteoglycan that are immunologically re- 
lated  to the  EHS proteoglycan. Heparitinase  digestion of 
the  proteoglycan fraction  from the  glomerular  basement 
membrane produced immunoreactive core proteins of Mr = 
250,000 and 200,000 as well as disperse, faint core protein 
at Mr =  150,000 (Fig. 2, lane E). These core proteins were 
not detected either in the undigested proteoglycan fractions 
(Fig. 2, lane F) or in the heparitinase preparation (Fig. 2, 
lane G). It was necessary to use four to five times more of 
the heparitinase digested proteoglycan fraction than the gly- 
coprotein fraction to produce the intensity of staining ob- 
served in these blots. This could be due to poor transfer of 
core proteins to nitrocellulose. Alternatively, it would indi- 
cate that the majority of the immunological determinants de- 
tected in the glomerular basement membrane lack glycos- 
aminoglycan side chains in situ. The reduction or absence 
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noprecipitated from a lysate of pulse-labeled glomeruli and were 
subjected to electrophoresis on polyacrylamide gels. The lysate was 
run directly on the gels (lane A) or proteins in the lysate were immu- 
noprecipitated with antibodies to laminin (lane B), antibodies to the 
EHS proteoglycan (lane C) and preimmune serum (lane D). Sam- 
ples were reduced betbre  electrophoresis. The running get was 
7.5 % polyacrylamide. Arrowheads denote the position of the dou- 
blet in lane B. 
laminin (Ledbetter et al.,  1985).  Indeed, antibodies to the 
EHS proteoglycan immunoprecipitated this precursor pro- 
tein (Mr  =  400,000) and no other proteins from the lysate 
(Fig. 3, lane C). This protein can be observed in the whole 
lysate but only  in  overexposed fluorograms (not  shown). 
Preimmune serum did not immunoprecipitate any proteins 
from the lysate (Fig. 3, lane D). These results indicate that 
the cells of glomeruli in organ culture synthesize the same 
size  chains  of laminin  as  well  as  the  same  size  (Mr  = 
400,000) precursor protein to the EHS proteoglycan as was 
previously identified by immunoprecipitation from lysates of 
labeled EHS cells (Ledbetter et al.,  1985). 
The ability of antibodies to the glomerular proteoglycan to 
immunoprecipitate the Mr =  400,000 precursor protein syn- 
thesized by EHS cells was also examined. Lysates of EHS 
cells,  radiolabeled in culture for 20 min with [35S]methio- 
nine, were immunoprecipitated with antibodies to laminin 
(Fig. 4, lane A), to the EHS proteoglycan (Fig. 4, lane B), 
and to the glomerular proteoglycan (Fig. 4, lane C).  Anti- 
bodies to the glomerular proteoglycan (Fig. 4, lane C) immu- 
noprecipitated the same precursor protein (Mr  =  400,000) 
identified by the antibodies to the EHS proteoglycan (Fig. 4, 
lane B). This indicates that EHS and glomerular proteogly- 
cans share some common antigenic determinants. The anti- 
bodies to the glomerular proteoglycan also immunoprecipi- 
tated a small amount of the A and B chains of laminin. The 
lower molecular weight components observed in lanes B and 
C  (Fig.  4) were present in precipitates obtained with pre- 
immune serum (Fig.  4,  lane D) and are considered to be 
nonspecific. 
Trypsin and V-8 protease digests of the EHS proteoglycan 
were subjected to electrophoresis and then reacted with anti- 
body to the glomerular proteoglycan in Western blots. Tryp- 
sin  produced a  major  fragment of Mr  =  200,000  (P200) 
(Fig. 5, lane A) whereas V-8 protease produces a number of 
of staining in lanes containing the same amount of  undigested 
proteoglycan (Fig.  2,  lanes  C  and F)  may be due to  the 
limited migration of the intact proteoglycan into the poly- 
acrylamide gel, its failure to transfer well to the nitrocellu- 
lose paper, reduced binding of  proteoglycan to nitrocellulose 
or steric hinderance (by heparan sulfate chains) of antibody 
binding. 
Next, we metabolically radiolabeled glomeruli in vitro for 
20  min  with  [35S]methionine  and  used  antibodies  to  the 
EHS  proteoglycan to  identify the  precursor protein(s)  to 
these immunoreactive proteins and proteoglycans. The mate- 
rial synthesized in only 20 min would still be inside the cells 
and would not have all posttranslational modifications, such 
as glycosaminoglycan side chain addition or proteolytic pro- 
cessing (Ledbetter et al.,  1985). Electrophoresis of the glo- 
merular  lysate  on  SDS-polyacrylamide gels  followed by 
fluorography showed a  variety of labeled proteins (Fig.  3, 
lane A). Antiserum to laminin was used as a positive control 
and to produce high molecular weight markers. This antise- 
rum  immunoprecipitated a  major  band  at Mr  =  220,000 
which represents the B chain(s) of laminin, and a doublet at 
Mr =  400,000 (Fig. 3, lane B). The lower band in the dou- 
blet is likely to be the A chain of laminin while the upper 
band is probably the precursor protein to the proteoglycan 
which has been shown to coprecipitate with antibodies to 
Figure 4.  Fluorograph of [3SS]methionine-labeled  proteins immu- 
noprecipitated from a lysate of pulse labeled EHS cells and were 
subjected to electrophoresis on polyacrylamide gels. Immunopre- 
cipitates from antibodies to lanlinin (lane A), antibodies to EHS 
proteoglycan (lane B), antibodies to glomerular proteoglycan (lane 
C) and preimmune serum (lane D). Samples were reduced before 
electrophoresis. Running gel was 7.5% polyacrylamide. 
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and 44,000 (P44) are derived from the P200 fragment (Led- 
better et al.,  1986). The trypsin (Fig. 5, lanes B and C) and 
the V-8 protease (Fig. 5, lanes E and F) produced peptides 
reacted similarly with antibodies to both the glomerular and 
the EHS proteoglycan. This extensive cross-reaction sug- 
gests that the EHS and glomerular proteoglycans share many 
antigenic  determinants.  The  antibodies  to  these  two pro- 
teoglycans did not, however, react equally with all the pep- 
tide fragments.  For example, antibodies to the glomerular 
proteoglycan did not appear to react with the P44 and P46 
fragments (Fig. 5, lane F) with the same relative intensity 
as the antibody to the EHS proteoglycan (Fig.  5,  lane E). 
Consequently, we used the more quantitative ELISA on mi- 
crotiter plates to measure the reactivity of these antibodies 
with purified P44, P46, and P200 fragments from the EHS 
proteoglycan. Antibodies to the EHS proteoglycan reacted 
strongly with the P44  and  P46  fragments and  even more 
strongly with the P200 fragment (Fig.  6  B) as previously 
shown (Ledbetter et al., 1986). In comparison, antibodies to 
the glomerular proteoglycan reacted strongly with the P46 
and P200 fragment but reacted only very weakly with the 
P44 fragment (Fig.  6 A).  These results indicate that while 
immunological determinants on the P46 peptide were pres- 
ent on the glomerular proteoglycan used as antigen, the de- 
terminants on the P44 peptide were substantially reduced or 
absent from the glomerular poteoglycan. 
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Figure  6.  Immunoreaction of antibodies to basement membrane 
proteoglycans with the P44, P46 and P200 fragments from the EHS 
proteoglycan using ELISA with microtiter wells. Wells were coated 
overnight at 4~  with a solution containing the amount of fragment 
designated on the horizontal axis. (A) Antibodies to glomerular pro- 
teoglycan; (B) antibodies to EHS proteoglycan. 
Figure  5.  Immunoreaction of antibodies to basement membrane 
proteoglycans with proteolytic digests of EHS proteoglycan were 
subjected to electrophoresis on polyacrylamide gels and transferred 
to nitrocellulose.  Proteoglycan was  digested with either  trypsin 
for 2 h or V8 protease for 8 h and applied without reduction to 
polyacrylamide gels containing 5 % running gels. 10 pg of digested 
proteoglycan was applied for amido black staining and 3 [tg for im- 
munostaining. Lane A, amido black staining of  trypsin digests; lane 
B immunostaining of trypsin digests with antibodies to EHS pro- 
teoglycan; lane C, immunostaining of trypsin digests with antibod- 
ies to glomerular proteoglycan; lane D, amido black staining of V8 
protease digests; lane E, immunostaining of V8 digests with anti- 
bodies to EHS proteoglycan; lane F, immunostaining of V8 digests 
with antibodies to glomerular proteoglycan. Arrowheads point to 
migration position of Mr = 44,000 and 46,000 fragments produced 
by digestion with V8 protease. 
Discussion 
Studies from several laboratories (Kanwar et al.,  1981; Stow 
et al.,  1983;  Parthasarathy and Spiro,  1984; Kanwar et al., 
1984; Klein et al., 1986; Edge and Spiro, 1987) show that the 
heparan  sulfate  containing  proteoglycan from glomerular 
basement membrane is smaller than the EHS proteoglycan 
(Hassell et al.,  1986). Some of the smaller size is due to the 
presence of smaller size heparan sulfate side chains on the 
glomerular proteoglycan. Side chains, it should be noted, are 
posttranslational modifications and their size is probably de- 
termined more by the glycosaminoglycan synthesizing sys- 
tem in the cell than by the precursor protein acceptor (Led- 
better et al.,  1985). The relationship between proteoglycans 
can be more accurately established by characteristics, such 
as size and immunological determinants of their core pro- 
teins or better still, of their precursor proteins. 
We have been using the EHS tumor as a model system to 
characterize the core protein of a basement membrane pro- 
teoglycan which contains heparan sulfate side chains.  This 
proteoglycan is synthesized from a Mr =  400,000 precursor 
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Figure 7. Structural models of EHS and glomemlar proteoglycans. 
The model of the EHS proteoglycan is based on peptide mapping 
(Ledbetter et al.,  1987) and  electron microscope visualization 
(Laurie et ai., 1987) as described in the discussion. The results of 
the studies in this report indicate the glomerular pmteoglycans are 
derived from the same large precursor protein as the EHS pro- 
teoglycan  but that is proteolytically  processed to a smaller core pro- 
tein containing the P46 region but not the P44 region of the EHS 
proteoglycan. 
protein  (Ledbetter et al.,  1985) and  consists of a  Mr  = 
400,000  core protein containing three heparan sulfate side 
chains of Mr  =  65,000  (Hassell et al.,  1985b; Kato et al., 
1985). The core protein is divided equally into a trypsin sen- 
sitive domain containing the side chains and a trypsin resis- 
tant domain (P200)  containing two  V8  protease  resistant 
regions of M~ =  44,000 (P44) and M, =  46,000 (P46) (Led- 
better et al., 1986). A structural model of  the EHS proteogly- 
can showing the location of the P200, P44 and P46 fragments 
within the M,  =  400,000  core protein has been proposed 
(Ledbetter et al., 1986). Recent electron microscopic exami- 
nation of this proteoglycan shows the side chains extending 
from one end of the core protein (Laurie et al., 1988; Pauls- 
son et al.,  1987; Yurchenco et al.,  1987) and this model of 
the EHS proteoglycan is now redrawn (Fig. 7) for compari- 
son with the glomerular proteoglycan. 
The experiments in this study,  using antibodies to EHS 
proteoglycan, show glomerular cells synthesize the same 
size (Mr  =  400,000)  precursor protein known to be con- 
verted to the major heparan sulfate proteoglycan in EHS cells 
(Ledbetter et  al.,  1985). These  antibodies  also  detected 
heparan sulfate proteoglycan in extracts of glomeruli and 
glomerular basement membranes that have core proteins 
ranging in size from Mr =  150,000 to 400,000  with a M, = 
250,000  species being most prevalent. It is likely that this 
large precursor protein synthesized by glomerular cells is 
used for the production of glomerular heparan sulfate pro- 
teoglycan and that proteolytic processing produces proteo- 
glycans with a  range of core protein sizes.  The relatively 
more diffuse core protein bands compared to the sharper pre- 
cursor protein band probably reflects greater variations in 
posttranslational modifications such as proteolytic process- 
ing and oligosaccharide addition, of the core proteins. Fur- 
thermore, antibodies to the glomerular proteoglycan confirm 
the immunological cross reaction between EHS and glomer- 
ular proteoglycans.  These  antibodies  immunoprecipitated 
the Mr  =  400,000  precursor protein synthesized by EHS 
cells and reacted with most of the proteolytic fragments of 
the EHS proteoglycan, including the P46  fragment but not 
the P44  fragment. It is possible that the glomerular pro- 
teoglycan used as an antigen was proteolytically clipped in 
the P200 domain of the M, =  400,000 precursor protein, ei- 
ther before or after heparan sulfate addition, to produce a 
proteoglycan with a core protein containing the P46 deter- 
minants but lacking the P44 fragment as illustrated in Fig. 7. 
The antibodies to the EHS proteoglycan detected heparan 
sulfate proteoglycans with core proteins of Mr  =  250,000 
and larger from glomeruli, and cores of M, =  250,000 and 
smaller from glomerular basement membrane. These obser- 
vations may indicate that the proteoglycan components iso- 
lated  from  glomerular  basement  membrane  preparations 
have been proteolytically processed further than those iso- 
lated from glomeruli. Alternatively, since it has been shown 
(Brown et al., 1981) that at least 95 % of the 35SO4 incorpo- 
rated into giomeruli is lost during the isolation of  glomerular 
basement membrane, the appearance of these smaller core 
proteins and glycoproteins may be due instead to the selec- 
tive loss of the proteoglycans with the larger core proteins 
during the procedure used to isolate the glomerular base- 
ment membrane. 
The size of the core proteins found for glomerular heparan 
sulfate proteoglycans in this report are considerably larger 
than the Mr  =  18,000 reported by Kanwar et al. (1984) but 
only slightly larger than the Mr =  143,000 recently reported 
by Edge and Spiro (1987). The differences are likely to be 
technical. Firstly, to reduce tissue handling, we isolated pro- 
teoglycans directly from glomeruli and these proteoglycans 
proved to have the largest core proteins. Secondly, the pro- 
teoglycans were isolated by DEAE-column chromatography 
only, thereby reducing either the possibility of additional 
proteolysis or the selection of one form of proteoglycan dur- 
ing purification. Finally, although the proteoglycans were 
not rigorously purified, detection of the core proteins relied 
upon the specificity of both the heparitinase and an affinity 
purified antibody which has been shown to immunolocalize 
only to basement membranes in tissue sections and immuno- 
precipitate only one precursor protein. 
An unexpected finding of this study was the presence of 
Mr  =  200,000  and 150,000 glycoproteins in glomeruli and 
glomerular basement membrane that reacted with the anti- 
body to the EHS proteoglycan. These immunologically re- 
lated glycoproteins are also likely produced by proteolytic 
processing  of the  Mr  =  400,000  precursor  protein  and 
would not be detected in other studies, where core proteins 
are defined only by the presence of glycosaminoglycan side 
chains. An analogous situation exists in cartilage where a 
fragment of the cartilage proteoglycan containing a  func- 
tional hyaluronic acid-binding region but not glycosamino- 
glycan side chains has been identified as a component of the 
cartilage matrix (Roughley et al., 1985; Roughley and Mort, 
1986). The glycoprotein fragments from the core protein of 
the glomerular proteoglycan may have functional properties 
of their own as well. 
The presence of  proteoglycan in basement membranes was 
first suggested by histological studies showing staining of 
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aminoglycans (Bernfield and Banerjee,  1972; Trelstad et al., 
1974; Caulfield and  Farquhar  1976). Heparan  sulfate  pro- 
teoglycans  isolated  from  different  basement  membranes, 
however, have been shown to range  in size from large  (Mr 
=  600,000)  to small (Mr  =  130,000)  (for reviews see Has- 
sell et al., 1986; Poole, 1986; Gallagher et al., 1986).  Anti- 
bodies  prepared  to date  against  these  apparently  different 
proteoglycans localize to all basement membranes (Hassell 
et al.,  1980; Stow et al., 1985; Fenger et al., 1984; Eldridge 
et al., 1986; Brenchley,  P. E., M. A. J. Dickinson, and J. C. 
Anderson, manuscript in preparation).  These antibodies rec- 
ognize only one (Mr =  400,000) precursor protein (Ledbet- 
ter et al.,  1985;  Hassell et al.,  1985a;  Wewer et al.,  1985; 
Eldrich et al.,  1986; Singer et al.,  1987; this report)  from a 
variety  of cell types.  Furthermore,  metabolic studies with 
basement membrane producing cells in culture show that at 
least a portion of the population of small proteoglycans are 
derived from larger  ones (Ledbetter  et al.,  1985;  Kinsella 
and Wight,  1985).  Thus, proteolytic processing of the Mr = 
400,000 precursor protein to a smaller core protein of a pro- 
teoglycan may be a recurrent  theme in the biosynthesis of 
basement membrane proteoglycans. This processing, or core 
protein "tailoring" would produce a proteoglycan which fits 
the  functional  requirements  of an  endothelial,  epithelial, 
muscle, adipose, or neuronal basement membrane. Remov- 
ing selected regions of the core might affect the proteogly- 
cans interaction with other basement membrane components, 
change its matrix location and possibly modify its function 
as well. 
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